Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:28:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history now shows a new site revision (v3.4.2) replacing v3.4.1; there are no substantive updates to study records or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T12:34:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed. This is a minor metadata update to the page history with no impact on study content or data.
    Difference
    0.1%
    Check dated 2026-02-04T07:30:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a Show glossary option and color-coded indicators for changes (green for additions, red for deletions). The revision label was updated to v3.4.0, replacing the previous v3.3.4.
    Difference
    0.9%
    Check dated 2026-01-28T05:40:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new revision (v3.3.4) was added to the study record history, and the previous revision (v3.3.3) was removed, indicating a bookkeeping update to the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 was added to the study record history, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the page.
    Difference
    0.2%
    Check dated 2025-12-23T10:19:00.000Z thumbnail image

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.